Canakinumab for the management of pyoderma gangrenosum: a case series of two patients and literature review

Aims To evaluate the efficacy and adverse events of canakinumab in the treatment of pyoderma gangrenosum (PG).Methods We report two cases of refractory PG treated with canakinumab after failing multiple therapies.Results A 44-year-old female achieved complete ulcer resolution after 31 months of cana...

Full description

Saved in:
Bibliographic Details
Main Authors: Howard Jie Yang, William Spratt, Francis Yi Xing Lai, Senhong Lee
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Journal of Dermatological Treatment
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/09546634.2025.2495834
Tags: Add Tag
No Tags, Be the first to tag this record!